The Zimbabwean government has introduced a groundbreaking HIV prevention method in the form of a two-month lasting injection.
The drug, Injectable cabotegravir (CAB_LA), is now available for pre-exposure prophylaxis (PrEP), offering a cutting-edge biomedical solution to prevent HIV transmission among individuals at high risk. Unlike the conventional daily regimen of pills required for PrEP, this injection is administered just once every two months, providing a more convenient and manageable option for those seeking protection against the virus.
Dr. Misheck Ruwende, a respected figure in the medical community, commented on the development, stating, “Good news! Zimbabwe administered its first HIV prevention injection today. This injection offers a more convenient alternative to daily pills (PrEP), as it is administered once every two months.”
